Effects of benazepril on cardiac fibrosis in STZ-induced diabetic rats

References

• Korosoglou G, Humpert PM. Non-invasive diagnostic imag-ing techniques as a window into the diabetic heart: a reviewof experimental and clinical data. Exp ClM Endocrinol Diabetes 2007; 115: 211–20.
   Google Scholar
• Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardio-myopathy: mechanisms, diagnosis and treatment. ClM Sci (Lond) 2004; 107: 539–57.
   Google Scholar
• Loganathan R, Bilgen M, Al-Hafez B, Smirnova W Charac-terization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging 2006; 22: 81–90.
   Google Scholar
• Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47: 693–700.
   Google Scholar
• Tyagi SC, Rodriguez W, Patel AM, Roberts AM, Falcone JC, Passmore JC, Fleming JT, Joshua IG. Hyperhomocys-teinemic diabetic cardiomyopathy: oxidative stress, remod-eling, and endothelial-myocyte uncoupling. J Cardiovasc Pharmacol Ther 2005; 10: 1–10.
   Google Scholar
• Hudon-David F, Bouzeghrane F, Couture P, Thibault G. Thy-1 expression by cardiac fibroblasts: Lack of association with myofibroblast contractile markers. J Mol Cell Cardiol 2007; 42: 991–1000.
   Google Scholar
• Mori S, Gibson G, McTiernan CF. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model. J Card Fail 2006; 12: 314–25.
   Google Scholar
• Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J. Alterations in the pattern of collagen deposition may con-tribute to the deterioration of systolic function in hyperten-sive patients with heart failure. J Am Coll Cardiol 2006; 48: 89–96.
   Google Scholar
• Siwik DA, Colucci WS. Regulation of matrix metalloprotein-ases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004; 9: 43–51.
   Google Scholar
• Cleutj ens JP. The role of matrix metalloproteinases in heart disease. Cardiovasc Res 1996; 32: 816–21.
   Google Scholar
• Lee SW, Song KE, Shin DS, Ahn SM, Ha ES, Kim DJ, Nam MS, Lee KW Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes. Diabetes Res Clin Pract 2005; 69: 175–9.
   Google Scholar
• Bollano E, Omerovic E, Svensson H, Waagstein F, Fu M. Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in dia-betic rats. Int J Cardiol 2007; 114: 195–201.
   Google Scholar
• Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LM. Angiotensin II-mediated phe-notypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 2005; 46: 426–32.
   Google Scholar
• Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, Ferrario CM, Raizada MK. Protection from angiotensin II-induced cardiac hypertrophy and fibro-sis by systemic lentiviral delivery of ACE2 in rats. Exp Phys-iol 2005; 90: 783–90.
   Google Scholar
• Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM. Aldosterone mediates angiotensin II-induced intersti-tial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J2006; 20: 1546-8.
   Google Scholar
• Rahmani M, Cruz RP, Granville DJ, McManus BM. Allo-graft vasculopathy versus atherosclerosis. Circ Res 2006; 99: 801–15.
   Google Scholar
• Hong HJ, Chan P, Liu JC, Juan SH, Huang MT, Lin JG, Cheng TH. Angiotensin II induces endothelin-1 gene expres-sion via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc Res 2004; 61: 159–68.
   Google Scholar
• Shi-Wen X, Denton CP, Dashwood MR, Holmes AM, Bou-Gharios G, Pearson JD, Black CM, Abraham DJ. Fibrob-last matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol 2001; 116: 417–25.
   Google Scholar
• Papadopoulos DP, Economou EV, Makris TK, Kapetanios KJ, Moyssakis I, Votteas YE, Toutouzas PK. Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction. Drugs Exp Clin Res 2004; 30: 55–65.
   Google Scholar
• Zierhut W, Studer R, Laurent D, Kästner S, Allegrini P, Whitebread S, Cumin F, Baum HP, de Gasparo M, Drexler H. Left ventricular wall stress and sarcoplasmic reticulum Ca(2 +)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade. Cardiovasc Res 1996; 31: 758–68.
   Google Scholar
• Hu QW, Liu GT. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action. Life Sci 2006; 79: 606–12.
   Google Scholar
• Ueshima K, Shibata M, Suzuki T, Endo S, Hiramori K. Extracellular matrix disturbances in acute myocardial infarc-tion: relation between disease severity and matrix metallo-proteinase-1, and effects of magnesium pretreatment on reperfusion injury. Magnes Res 2003; 16: 120–6.
   Google Scholar
• Li J, Schwimmbeck PL, Tschope C, Leschka S, Husmann L, Rutschow S, Reichenbach F, Noutsias M, Kobalz U, Poller W, Spillmann F, Zeichhardt H, Schultheiss HP, Pauschinger M. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc Res 2002; 56: 235–47.
   Google Scholar
• Reddy HK, Tjahja IE, Campbell SE, Janicki JS, Hayden MR, Tyagi SC. Expression of matrix metalloproteinase activ-ity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem 2004; 264: 183–91.
   Google Scholar
• Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2006; 65: 40–51.
   Google Scholar
• Tschope C, Walther T, Koniger J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 2004; 18: 828–35.
   Google Scholar
• Mihm MJ, Seifert JL, Coyle CM, Bauer JA. Diabetes related cardiomyopathy time dependent echocardiographic evalu-ation in an experimental rat model. Life Sci 2001; 69: 527–42.
   Google Scholar
• Van Linthout S, Seeland U, Riad A, Eckhardt 0, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic car-diomyopathy. Basic Res Cardiol 2008; 103: 319–27.
   Google Scholar
• Herpel E, Singer S, Flechtenmacher C, Pritsch M, Sack FU, Hagl S, Katus HA, Haass M, Otto HF, Schnabel PA. Extra-cellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies. Virchows Arch 2005; 446: 369–78.
   Google Scholar
• Hayden MR, Sowers JR, Tyagi SC. The central role of vas-cular extracellular matrix and basement membrane remod-eling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 2005; 4: 9.
   Google Scholar
• Dollery CM, McEwan JR, Henney AM. Matrix metallo-proteinases and cardiovascular disease. Circ Res 1995; 77: 863–8.
   Google Scholar
• Varagic J, Frohlich ED. Local cardiac renin-angiotensin sys-tem: hypertension and cardiac failure. J Mol Cell Cardiol 2002; 34: 1435–42.
   Google Scholar
• Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angio-tensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 2004; 286: C779–784.
   Google Scholar
• Kim MP, Zhou M, Wahl LM. Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for ather-osclerotic plaque rupture. J Leukoc Biol 2005; 78: 195–201.
   Google Scholar